BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia

[Image: see text] The therapeutic treatment of negative symptoms and cognitive dysfunction associated with schizophrenia is a significant unmet medical need. Preclinical literature indicates that α7 neuronal nicotinic acetylcholine (nACh) receptor agonists may provide an effective approach to treati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ACS Med Chem Lett
Main Authors: King, Dalton, Iwuagwu, Christiana, Cook, Jim, McDonald, Ivar M., Mate, Robert, Zusi, F. Christopher, Hill, Matthew D., Fang, Haiquan, Zhao, Rulin, Wang, Bei, Easton, Amy E., Miller, Regina, Post-Munson, Debra, Knox, Ronald J., Gallagher, Lizbeth, Westphal, Ryan, Molski, Thaddeus, Fan, Jingsong, Clarke, Wendy, Benitex, Yulia, Lentz, Kimberley A., Denton, Rex, Morgan, Daniel, Zaczek, Robert, Lodge, Nicholas J., Bristow, Linda J., Macor, John E., Olson, Richard E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Chemical Society 2017
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5346989/
https://ncbi.nlm.nih.gov/pubmed/28337332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.7b00032
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados